-
Preliminary study of tissue distribution and safety of HSV-2 DNA vaccine in mice
- JIAO Fengping, ZHANG Haitao, ZHAO Yinghui, TIAN Zhaoju, YANG Shulin
-
JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES). 2017, 55(7):
38-42.
doi:10.6040/j.issn.1671-7554.0.2016.856
-
Abstract
(
2531 )
PDF (1080KB)
(
475
)
Save
-
References |
Related Articles |
Metrics
Objective To investigate preliminarily the tissue distribution and safety of HSV-2 DNA vaccine pc-P6-gBCTL-TBK-1 in mice. Methods The recombinant plasmid pc-P6-gBCTL-TBK-1 was injected into BALB/c mice with 100 μg per mouse for three times at every other week. Heart, liver, spleen, kidney, lung, brain, blood and muscle tissues of immune mice were collected at 24 h, 7 d, 21 d, 35 d and 49 d after inoculation, then total DNAs of tissues were extracted, and the tissue distribution of plasmid DNA and the possibility of integration with host genome were detected by PCR assay. Results At 24 h, 7 d, 21 d and 35 d after the last immunization, the plasmid DNA was detected in heart, liver, spleen, kidney, lung, brain and muscle tissues. At 49 d after the last immunization, the plasmid DNA was detected only in muscle tissue. The gel-purified genomic DNA was detected negative by PCR assay. Conclusion The plasmid pc-P6-gBCTL-TBK-1 can spread quickly to the heart, liver, spleen, kidney, lung, brain, blood and muscle tissues of the mice. With the extention of time, the plasmid DNA only distributes in muscle tissue of vaccination, and the DNA does not integrate with the host genome, which suggests that the plasmid is safe.